Gastroenterological & Surgical Clinical Society Support
Several key professional associations have announced society support for the TIF procedure with EsophyX device:
![AGA](https://www.endogastricsolutions.com/wp-content/uploads/2022/03/aga-2-1.png)
American Gastroenterological Association (AGA) [1]
“The three‐year plus evidence is sufficient to demonstrate sustainable improvement in health outcomes, symptom relief, decrease in PPI utilization and improvement in esophageal pH with transoral fundoplication.”
![SAGES](https://www.endogastricsolutions.com/wp-content/uploads/2022/03/sages-2-1.png)
Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) [2]
![ASGE](https://www.endogastricsolutions.com/wp-content/uploads/2022/03/asge-2-1.png)
American Society for Gastrointestinal Endoscopy (ASGE) [3]
![ASGS](https://www.endogastricsolutions.com/wp-content/uploads/2022/03/asgs-2-1.png)
American Society of General Surgeons (ASGS) [4]
“Transoral fundoplication adheres to fundamental surgical principles. We also believe that there is a sufficient body of peer-reviewed literature that establishes transoral fundoplication as reasonable and medically necessary for a subset of patients who are candidates for surgical fundoplication; specifically, patients who either cannot obtain satisfactory relief from standard PPI therapy or who wish to avoid a lifetime of dependence on such medications, and present with a 2 centimeter or smaller hiatal hernia.”
![AMA](https://www.endogastricsolutions.com/wp-content/uploads/2022/03/ama-2-1.png)
The American Medical Association (AMA) [5]
![AFS](https://www.endogastricsolutions.com/wp-content/uploads/2022/03/afs-2-1.png)
American Foregut Society [6]
References:
[1] American Gastroenterological Association (AGA). Technology Coverage Statement on Minimally Invasive Surgical Options for Gastroesophageal Reflux Disease – April 2016.
[4] American Society of General Surgeons (ASGS). Position statement: Transoral fundoplication. 2011.